1Ross R. Atherosclerosis an inflammatory disease. N Engl J Med, 1999,340: 115-26.
2Davies ML. The pathogenesis of atherosclerosis: a perspective for dromes. Heart, 2000,83: 361 -- 6.
3Davies MJ. Reactive oxygen species, metallo-proteinase, and plaque stability. Circulation, 1998,97: 2382-3.
4Moreno PR, Falk E, Palacios IF, et al. Macrophage infiltration in acute coronary syndromes implications for plaque rupture.Circulation, 1994,90: 775--8.
5Davies ML,Richardson PD,Woolf N, et al. Risk of thrombosis in human atherosclerotic plaque: role of extracellular lipid,macrophage and smooth muscle cell content. Br Heart J, 1993,69:377-81.
6Libby P. Molecular basis of the acute coronary syndromes. Circulation, 1995,91 : 2844--50.
7Ridker PM, Rifai M, Pfeffer M, et al. Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction. Circulation, 2000, 101:2149-53.
8Ritchie ME. Nuclear factor-KappaB is selectively and markedly activated in humans with unstable angina pectoris. Circulation,1998,98: 1707-13.
9Mallat Z, Basnard S, Duriez M, et al. Protective role of interleukin- 10 in atherosclerosis. Circ Res, 1999,85: e 17--24.
10Garcia-Moll X, Zouridakis E,Cole D, et al. C-reactive protein in patients with chronic stable angina: differences in baseline serum concentration between women and men. Eur Heart J,2000,21 : 1598-606.
3Omalley T, Ludlam CA, Riemermsa RA, et al. Early increaseiv levels of soluble inter cellularmolecule-1 ( sICAM - 1 ). Potential risk factor for the coronary syndromes[J]. Eur Heart J,2001,22:1226 - 1234.
